|
IDF2022-0687 Characterization and efficacy of GNTI-122, a novel engineered regulatory T-cell therapy, for treating Type 1 Diabetes |
|
|
|
Titel: |
IDF2022-0687 Characterization and efficacy of GNTI-122, a novel engineered regulatory T-cell therapy, for treating Type 1 Diabetes |
Auteur: |
Uenishi, G. Landuyt, A. Yam, J. Saikumar-Lakshmi, P. Guo, T. Kieffer-Kwon, P. Chen, T. Repic, M. Wickham, T. Mueller, K. |
Verschenen in: |
Diabetes research and clinical practice |
Paginering: |
Jaargang 197 () nr. S1 pagina's p. |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|